Leukotrienes antagonist-inhibitor and the bronchial response to inhaled antigen in actively sensitized guinea-pigs.
The aim of the study was to estimate an eventual contribution of leukotrienes in respiratory mechanic changes observed in guinea-pig during bronchial anaphylaxis. Twenty-eight guinea-pigs, actively sensitized to ovalbumin, were anesthetized and curarized before being challenged, during controlled ventilation, with antigen administered as an aerosol. Antigen challenge was performed before and after pretreatment with nebulized FPL55712 and BW755C, respectively used as an antagonist of leukotrienes and as a cyclo-oxygenase/lipoxygenase inhibitor. The experiments were carried out during continuous recording of tracheal pressure (Ptr), airflow (V) and tidal volume (VT) signals variations evidencing respiratory asynchronism (AS) and allowing measurements of the changes in airway resistance (AR) and dynamic compliance (Cdyn) during all the challenge. Administration of nebulized ovalbumin was stopped at the onset of AS appearance chosen as the threshold of the antigen-induced bronchoconstriction. The results showed that separate or combined pretreatment with FPL55712 and BW755C did not significantly modify the threshold of the ovalbumin-induced bronchoconstriction in guinea-pigs. Nevertheless pretreatment with nebulized FPL55712 reduced significantly the intensity and the duration of the response of these animals to inhaled leukotriene D4 (LTD4). Moreover the response of guinea-pigs to inhaled LTD4, characterized by a starting decrease in Cdyn, appeared quite different from the response to the antigen starting by an abrupt rise in RA induced by a sudden bronchoconstriction. From these results, we concluded that leukotrienes seem not to be the main mediator of the bronchial anaphylaxis in guinea-pigs.
Marcelle
R
R
Institut Léon Frédéricq, Physiologie, Université de Liège, Belgium.
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine / Q000494:pharmacology*; D000280:Administration, Inhalation; D000818:Animals; D001985:Bronchial Provocation Tests; D002867:Chromones / Q000494:pharmacology*; D005260:Female; D006168:Guinea Pigs; D007114:Immunization; D020024:Leukotriene Antagonists / Q000494:pharmacology*; D017998:Leukotriene D4; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology*; D008297:Male; D010047:Ovalbumin / Q000276:immunology*; D013189:SRS-A / Q000037:antagonists & inhibitors / Q000502:physiology*
D002867:Chromones; D020024:Leukotriene Antagonists; D016859:Lipoxygenase Inhibitors; D013189:SRS-A; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D017998:Leukotriene D4; C006312:FPL 55712; D010047:Ovalbumin